ArticleBMC cancer2026

Dabrafenib or trametinib in pediatric Langerhans cell histiocytosis with bone lesions: a retrospective efficacy and safety study.

Haiping Ouyang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.